{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:08:01Z","timestamp":1761581281075},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.humpath.2015.01.018","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T02:17:47Z","timestamp":1423707467000},"page":"761-766","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases"],"prefix":"10.1016","volume":"46","author":[{"given":"Sheila F.","family":"Faraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alcides","family":"Chaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilda","family":"Gonzalez-Roibon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Munari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio L.","family":"Cubilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ie-Ming","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George J.","family":"Netto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2015.01.018_bb0005","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.humpath.2012.01.014","article-title":"Advances in the pathology of penile carcinomas","volume":"43","author":"Chaux","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0010","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.urology.2010.02.038","article-title":"Developments in the pathology of penile squamous cell carcinomas","volume":"76","author":"Chaux","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2015.01.018_bb0015","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.eururo.2010.01.039","article-title":"European Association of Urology Guidelines Group on Penile C. EAU penile cancer guidelines 2009","volume":"57","author":"Pizzocaro","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0020","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.juro.2006.11.038","article-title":"Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma","volume":"177","author":"Bermejo","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0025","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/annonc\/mdn149","article-title":"A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)","volume":"19","author":"Theodore","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrurol.2012.238","article-title":"Penile cancer: optimal management of T1G2 penile cancer remains unclear","volume":"10","author":"Chaux","year":"2013","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.critrevonc.2004.09.006","article-title":"Cancer of the penis","volume":"53","author":"Mosconi","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.juro.2010.03.145","article-title":"Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes","volume":"184","author":"Zhu","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-5347(05)64836-7","article-title":"p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy","volume":"168","author":"Lopes","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0050","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.juro.2013.06.015","article-title":"mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior","volume":"190","author":"Ferrandiz-Pulido","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/humu.21633","article-title":"Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types","volume":"33","author":"Jones","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.humpath.2015.01.018_bb0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/2159-8290.CD-12-0361","article-title":"ARID1A mutations in cancer: another epigenetic tumor suppressor?","volume":"3","author":"Wu","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2015.01.018_bb0065","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1158\/0008-5472.CAN-11-1562","article-title":"ARID1A, a factor that promotes formation of SWI\/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers","volume":"71","author":"Guan","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2015.01.018_bb0070","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0075","first-page":"89","article-title":"Practical methods for tissue microarray construction","volume":"103","author":"Fedor","year":"2005","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.humpath.2015.01.018_bb0170","first-page":"405","article-title":"Tumors of the prostate gland, seminal vesicles, penis, and scrotum","author":"Epstein","year":"2011"},{"key":"10.1016\/j.humpath.2015.01.018_bb0085","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/PAS.0b013e31819aa4c9","article-title":"Histologic grade in penile squamous cell carcinoma: visual estimation versus digital measurement of proportions of grades, adverse prognosis with any proportion of grade 3 and correlation of a Gleason-like system with nodal metastasis","volume":"33","author":"Chaux","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/PAS.0b013e3181c76a49","article-title":"The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay","volume":"34","author":"Cubilla","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/PAS.0b013e318212782a","article-title":"Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma","volume":"35","author":"Guan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0100","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/his.12338","article-title":"Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases","volume":"64","author":"Chaux","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2015.01.018_bb0105","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/PAS.0b013e31822895e5","article-title":"Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas","volume":"35","author":"Schultz","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/IGC.0b013e3182313d78","article-title":"Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas\/adenosquamous carcinomas of the uterine cervix","volume":"22","author":"Katagiri","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.humpath.2015.01.018_bb0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ygyno.2014.04.047","article-title":"MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A","volume":"134","author":"Wang","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0120","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.humpath.2012.11.007","article-title":"Loss of ARID1A\/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer","volume":"44","author":"Cho","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0125","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/modpathol.2011.161","article-title":"Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma","volume":"25","author":"Katagiri","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3802\/jgo.2014.25.1.58","article-title":"Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer","volume":"25","author":"Yokoyama","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0135","doi-asserted-by":"crossref","first-page":"e17517","DOI":"10.1371\/journal.pone.0017517","article-title":"Alternative HER\/PTEN\/Akt pathway activation in HPV positive and negative penile carcinomas","volume":"6","author":"Stankiewicz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2015.01.018_bb0140","doi-asserted-by":"crossref","first-page":"dju146","DOI":"10.1093\/jnci\/dju146","article-title":"Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis","volume":"106","author":"Guan","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2015.01.018_bb0145","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2407-14-120","article-title":"A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A\/BAF250a is associated with AKT phosphorylation","volume":"14","author":"Wiegand","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2015.01.018_bb0150","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/modpathol.2011.189","article-title":"Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations","volume":"25","author":"Yamamoto","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2015.01.018_bb0155","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/ng.2246","article-title":"Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes","volume":"44","author":"Zang","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2015.01.018_bb0160","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.18632\/oncotarget.2092","article-title":"Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition","volume":"5","author":"Samartzis","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2015.01.018_bb0165","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2008.17.3567","article-title":"A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers","volume":"26","author":"Camp","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T17:42:52Z","timestamp":1566322972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817715000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0046817715000441"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2015.01.018","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2015.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}